UPCOMING
Cancer Immunotherapy Summit
“Lessons learned from a clinical stage immunotherapy company with a novel platform technology”
Presentation by Dr. John Rothman, EVP of Science & Operations of Advaxis
February 27th, 2012
Boston, MA
6th Annual International BIO-Europe Spring 2012
Presentation by Tom Moore, CEO of Advaxis
March 19th-21st, 2012
Amsterdam RAI Convention Center
Amsterdam, the Netherlands
Society for General Microbiology
“Listeria monocytogenes for HPV-based cancer immunotherapy”
Presentation by Dr. John Rothman, EVP of Science & Operations of Advaxis
March 26th, 2012
Dublin, Ireland
World Vaccine Congress 2012
Presentation by Dr. John Rothman, EVP of Science & Operations of Advaxis
April 10th, 2012
Washington, DC
RECENT
14th Annual BIO Investor & CEO Conference
Presentation by Tom Moore, CEO of Advaxis
February 13th-14th, 2012
Waldorf=Astoria, NYC
Webcast